BioCentury
ARTICLE | Financial News

Neurocrine financial update

December 3, 2012 8:00 AM UTC

Neurocrine filed a shelf registration covering the sale of up to $150 million of its common stock. The company, which closed Friday at $7.48, has 66.4 million shares outstanding. ...